|
Quality Content… Invaluable Networking
IBC’s 8th International China Pharmaceutical R&D Summit is a premier industry event providing you with quality content including the changes and impact of the political environment, latest scientific innovations and advances, plus our targeted audience means invaluable networking opportunities for you.
A Must-Attend Event
International Companies:
This is your gateway to hear from, meet and network with domestic Chinese and other Regional drug developers and researchers.
Get up to speed with latest scientific advances and innovations in the region.
Use this opportunity to identify potential business partners and collaborators to secure your market share in China – expected to be the world’s second largest pharma market by 2015!
China-based Companies:
This is your opportunity to identify how you can benefit from the Chinese Government’s investment in innovation.
Understand the skills and resources needed to create an innovative environment.
Learn what investors are looking for and how to secure funding.
Showcase your innovations to an international market to secure your collaborator and take your business to the next level - take a step towards becoming an international player in the market! |
 |
 Barry Bernstein, MD
Global Head of Infectious Disease Development
Abbott Laboratories, USA |
 Jim O’Mara
Vice President Corporate Development
Ironwood Pharmaceuticals, USA |
 Augustine Yee
Head of Asia Pacific Corporate and Regional Development and China Vice President of Business Development
AstraZeneca, China |
 Ka-Kit Hui, MD, FACP
Wallis Annenberg Chair in Integrative East-West Medicine, Chair, Collaborative Centers for Integrative Medicine, Professor, Founder & Director, Center for East-West Medicine, Department of Medicine, UCLA, USA |
 Simone Song
Executive Director, IBD
Goldman Sachs (Asia) L.L.C, Hong Kong |
|
